ArticleFrontiers in neurology2026
Short-term changes in CRS-R scores during transcutaneous auricular vagus nerve stimulation in prolonged disorders of consciousness: a single-arm exploratory study.
Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To describe short-term behavioral changes observed during a 2-week transcutaneous auricular vagus nerve stimulation (taVNS) intervention in patients with prolonged disorders of consciousness (pDOC) and to exploratorily compare these changes across baseline diagnostic states. Methods: This single-center, single-arm, open-label exploratory study included 50 patients with pDOC (25 with VS/UWS, 16 with MCS-, and 9 with MCS+) who received taVNS in addition to standard care for 2 weeks. CRS-R assessments were conducted at baseline, week 1, and week 2. The primary outcome was the longitudinal change in the CRS-R total score across the three assessment time points. Results: At week 2, the mean change in CRS-R total score from baseline was 2.40 ± 2.08 points (95% CI, 1.81-2.99), with no significant difference among the diagnostic groups. Upward diagnostic transitions occurred in 9/25 (36.0%) patients with VS/UWS (VS → MCS-, Conclusion: Short-term CRS-R changes and diagnostic transitions were observed during the 2-week taVNS intervention. Because the study lacked a control group and used unblinded outcome assessment, these changes cannot be attributed specifically to taVNS. The subgroup and early-outcome analyses are exploratory and require confirmation in adequately powered, sham-controlled studies with blinded assessment and longer follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.